COSCIENS Biopharma Inc. (CSCI) - Net earnings per share (EPS TTM)

Symbol and logo of brand cosciensbio.com (CSCI)

COSCIENS Biopharma Inc. (CSCI) is optimizing the supply of rare biologics through global diversification to mitigate regulatory risks. Patents for hormonal deficiency diagnostics and FDA certification establish a sustainable market barrier. The Canadian business relies on exclusive rights and an international distribution network. Net income per share over the last four quarters demonstrates profit dynamics, with the indicator settling at -4.34.

CSCI (cosciensbio.com) Earnings per share for the last 12 months history from 08/10/2024 to 09/14/2025

Comprehensive metric breakdowns and analytics for COSCIENS Biopharma Inc (CSCI)

- share price and expert price forecast:
Stock Quotes COSCIENS Biopharma Inc.|CSCI - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization COSCIENS Biopharma Inc.|CSCI - Total Enterprise Value
- business book valuation details:
Book Value per Share COSCIENS Biopharma|CSCI - Accounting Capitalization|Market Cap to Net Assets Ratio cosciensbio.com|CSCI - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity COSCIENS Biopharma Inc.|CSCI - Long-Term Liabilities to Equity|Short-Term Debt to Capital Aeterna Zentaris|CSCI - Aggregate Debt Obligations|Debts to Book Capitalization COSCIENS Biopharma Inc.|CSCI - Company Long-Term Debts|Company Short-Term Debt COSCIENS Biopharma|Quick Liquidity cosciensbio.com
- net income and valuation multiples indicators:
CSCI - Net Income|Projected Future Earnings COSCIENS Biopharma Inc.|CSCI - P/E Multiple|Forward P/E Multiple COSCIENS Biopharma|CSCI - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization COSCIENS Biopharma Inc.|CSCI - Profit before interest, taxes and amortization|Earnings per share for the last twelve months COSCIENS Biopharma|CSCI - Net earnings per share for the last four quarters|Quarterly EPS earnings growth cosciensbio.com|CSCI - Net earnings per share growth this year|Earnings growth forecast for next year COSCIENS Biopharma Inc.
General company analysis:COSCIENS Biopharma Inc. (CSCI)
Mass-produced product of COSCIENS Biopharma Inc

Annual net earnings per share measures the actual business income allocated per share for an objective valuation. By analyzing changes in the rolling annual EPS, an investor can observe operational efficiency trends stripped of market noise. This calculation confirms the company's ability to generate profit from its assets. For COSCIENS Biopharma Inc. (CSCI), this indicator reflects the monetization of patents for diagnosing endocrine pathologies. The monopoly status of the drug Macrilen converts directly into the stability of this fundamental metric.

Competitors of COSCIENS Biopharma Inc. (CSCI)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp (UTHR)|BMRN (BioMarin Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio Corp)|Net earnings per share for the last 12 months BGM (BGM Group Ltd)|COGT (cogentbio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Therapeutics Inc) - Earnings per one share for the last 12 months|Arcturus Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Corp)|KMDA: Net earnings per share (EPS TTM)|fulcrumtx.com (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Abeona Therapeutics, Inc.|MREO: Earnings per share for the trailing year|Earnings per share for the last twelve months Protalix (PLX)|Net earnings per share for the last 12 months pliantrx.com PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics, Inc.)|Net earnings per share (EPS TTM) aileronrx.com RNTX|Gelteq Limited Inc - Net earnings per share (EPS TTM)|Aytu BioPharma, Inc. (AYTU) - Net earnings per share for the last 12 months|chemomab.com (CMMB) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months SRx Health Solutions (SRXH)|Earnings per share for the last twelve months Polyrizon Limited|Zentaris (AEZS) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) CYTH|Net earnings per share for the last 12 months inozyme.com INZY|Net earnings per share (EPS TTM) RPHM (Reneo Pharma)